- Cell and molecular biology
- Biomarkers
- Epidemiology, prevention and public health
- Experimental therapeutics and drug development
- Genetics, genomics and epigenetics
- Infection, immunity and cancer vaccines
- Medical and radiation oncology
- Surgical oncology, cancer imaging and interventional therapeutics
- Systems biology, post-genomic analysis and emerging technologies
- Supportive therapy, cancer burden and survivorship
New collection: Advances in CAR-T immunotherapy
Chimeric antigen receptor (CAR) T cells therapies, as a novel modality in cancer immunotherapy, provide a quantum leap in the treatment of cancer. BMC Cancer and BMC Biotechnology together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. Click on highlight to read the the full collection of articles.
Focus Issue Health Disparities
With World Humanitarian Day falling on 19th August, the BMC Series decided to focus on health disparities in August’s focus issue. Browse our biology, chemistry and medical titles for insight into health disparities, including racial health disparities, socioeconomic health disparities and regional disparities
BMC Series Focus Issue
September: Food science and nutrition
For the month of September, the BMC Series is proud to present the monthly focus issue dedicated to food science and nutrition. Browse our biology and medical titles for insight into recent research in the field, including food science, production and safety, food assistance and insecurities, probiotics, the gut, nutrition, diet and their effect on lifestyle and health.
Articles
-
-
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
-
Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model
-
FUT4siRNA augments the chemosensitivity of non-small cell lung cancer to cisplatin through activation of FOXO1-induced apoptosis
-
Survival outcomes in men with a positive family history of prostate cancer: a registry based study
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
Atypical glandular cells in conventional cervical smears: Incidence and follow-up
-
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma
Featured review: Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico
Gallbladder cancer is a rare malignancy of the biliary tract with a poor prognosis, frequently presenting at an advanced stage. While rare in the United States overall, gallbladder cancer has an elevated incidence in geographically distinct locations of the globe including Chile, North India, Korea, Japan and the state of New Mexico in the United States. Rama R. Gullapalli, Associate Editor for BMC Cancer provides this review.
Featured video: Microparticles, breast cancer's secret weapon?
Your browser needs to have JavaScript enabled to view this video
Featured review: A stepwise approach to constructing systematic reviews
Systematic reviews, with or without meta-analysis, play an important role today in synthesizing cancer research and are frequently used to guide decision-making. With a focus on cancer, first author, Prof Kelley, provides a practical, stepwise approach for systematically reviewing the literature and publishing the results.
Featured article: Are cancer patients better off if they participate in clinical trials?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Aims and scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
Journal Sections
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last 6 months!
Read our highly accessed articles
Editorial: Nobel Prize Cancer Immunotherapy!
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
BMC Series Blog
-
Highlights of the BMC Series: August 2020
18 September 2020
-
What influences NHS Health Check behaviors?
17 September 2020
-
Follow
2019 Journal Metrics
-
Citation Impact
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)Usage
4,151,734 downloads
Social Media Impact
3364 mentions
